This study reveals that Lycium barbarum alleviates SIMI by modulating the NRF2/HO‐1 signaling pathway, positioning it as a novel therapeutic candidate for sepsis‐associated cardiac complications. This evidence concerns the gene HMOX1 and Sepsis.